AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massé, P. G
Right arrow Articles by Dosy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massé, P. G
Right arrow Articles by Dosy, J.
Agricola
Right arrow Articles by Massé, P. G
Right arrow Articles by Dosy, J.
American Journal of Clinical Nutrition, Vol. 80, No. 4, 946-951, October 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

B-6 vitamers and 4-pyridoxic acid in the plasma, erythrocytes, and urine of postmenopausal women1,2,3

Priscille G Massé, J Dennis Mahuren, Carole Tranchant and Juliana Dosy

1 From the School of Nutrition, University of Moncton, Moncton, Canada (PGM, CT, and JD), and the Fort Wayne State Developmental Center, Fort Wayne, IN (JDM and SPC).

Background: Although many studies have reported reduced vitamin B-6 status with aging, little information is available about the specific effects of menopause.

Objective: We aimed to examine vitamin B-6 metabolism in premenopausal and early postmenopausal women.

Design: We examined dietary intake and vitamin B-6 metabolites in the plasma, erythrocytes, and urine of 30 premenopausal women ( ± SD age: 41.9 ± 4.8 y) and 30 women (aged 54.0 ± 3.8 y) who were 4.0 ± 1.4 y past menopause.

Results: Vitamin B-6 intake in the postmenopausal group (1.97 ± 0.40 mg/d) was significantly greater than that in the premenopausal group (1.63 ± 0.50 mg/d). Plasma pyridoxal phosphate (PLP) and pyridoxal concentrations and erythrocyte PLP, pyridoxal, and pyridoxamine phosphate concentrations were in the normal range in both groups and did not differ significantly between the 2 groups. Plasma and erythrocyte 4-pyridoxic acid (4-PA) concentrations were significantly higher in the postmenopausal group than in the premenopausal group, which may have been due at least partly to the slightly higher vitamin B-6 intake of the former group. Erythrocyte 4-PA was correlated (r = –0.37, P < 0.01) with serum estradiol in both groups. Urinary 4-PA did not differ significantly between the 2 groups. The serum phosphate concentration was higher in the postmenopausal group than in the premenopausal group, and it was correlated (r = 0.40, P < 0.01) with plasma PLP. Inhibition of alkaline phosphatase by the increased phosphate may help to increase plasma PLP.

Conclusion: Menopause may not necessarily be associated with a decrease in vitamin B-6 status.

Key Words: Vitamin B-6 • menopause • aging




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
E. K. Wei, E. Giovannucci, J. Selhub, C. S. Fuchs, S. E. Hankinson, and J. Ma
Plasma Vitamin B6 and the Risk of Colorectal Cancer and Adenoma in Women
J Natl Cancer Inst, May 4, 2005; 97(9): 684 - 692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition